Article By:
Rod Raynovich
Thursday, July 19, 2018 12:16 PM EDT
Biotechs cruised through the choppy market of late June to rally with many mid-caps rolling up and major ETFs up creeping toward 2018 highs. However, with earnings reports coming up, we could expect some selling depending on top line growth.